Mariner
NMTC icon

Mariner’s NeuroOne Medical Technologies NMTC Stock Holding History

Mariner’s Portfolio NMTC Stock Details NMTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,737
Closed -$8.09K – 3780
2026
Q1 		$8.09K Sell
1,737
-2
-0.1% -$10 ﹤0.01% 3531
2025
Q4 		$7.91K Buy
+1,739
New +$7.92K ﹤0.01% 3514
2025
Q3 		– Sell
-1,745
Closed -$7.1K – 3696
2025
Q2 		$7.1K Buy
+1,745
New +$6.44K ﹤0.01% 3456

Other funds holding NMTC

BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BA
Bard Associates Chicago, Illinois $451M AUM 66.6% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Mariner's NMTC Position: Q2 2026 in Review

Mariner sold out of NeuroOne Medical Technologies (NMTC) in Q2 2026, closing a stake of 1,737 shares — an estimated $8.09K sold.

Mariner first reported a position in NMTC in Q2 2025 and held it in 3 quarters. The position peaked at $8.09K in Q1 2026. 27 funds tracked by Wall St. Rank hold NMTC as of Q2 2026.

  • Mariner reported no remaining NeuroOne Medical Technologies position as of Q2 2026 after selling out during the quarter.
  • Mariner sold 1,737 NeuroOne Medical Technologies shares in Q2 2026, an estimated $8.09K.
  • Mariner first reported a position in NeuroOne Medical Technologies in Q2 2025 and held it in 3 quarters.
  • Mariner's NeuroOne Medical Technologies position peaked at $8.09K in Q1 2026.
  • 27 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.